论文部分内容阅读
目的探讨预见性给予欣母沛对产后出血的影响。方法选取2013年9月-2015年9月该院收治的216例有宫缩乏力征兆和产后出血高危因素的患者为研究对象,随机分为观察组和对照组,每组各108例。观察组预见性给予欣母沛治疗,对照组采用常规宫缩素,分析两组产后出血的发生率、术中和术后出血量、手术时间以及血红蛋白的变化情况。结果观察组产后出血率、术中及术后24 h的出血量均低于对照组(4.63%vs.11.11%;414.62±204.23 ml vs.536.82±223.82 ml;477.54±215.82 ml vs.742.85±242.44 ml),差异均有统计学意义(均P<0.05);血红蛋白的降低值上,对照组高于观察组(2.14±0.60 g/L vs.1.47±0.42)g/L,差异有统计学意义(P<0.05)。结论预见性给予欣母沛能够有效减少术中及术后的出血量,缓解血红蛋白下降,值得临床推广使用。
Objective To investigate the predictive effect of Xinmaopei on postpartum hemorrhage. Methods A total of 216 patients with signs of uterine atony and high risk of postpartum hemorrhage admitted to our hospital from September 2013 to September 2015 were selected as study subjects and randomly divided into observation group and control group with 108 cases in each group. The observation group was given prospective Yanxin Pei treatment, and the control group was treated with conventional orifixibles. The incidence of postpartum hemorrhage, intraoperative and postoperative bleeding, operation time and hemoglobin were analyzed. Results The postpartum hemorrhage rate in the observation group was significantly lower than that in the control group at 24 h (4.63% vs.11.11%; 414.62 ± 204.23 ml vs.536.82 ± 223.82 ml; 477.54 ± 215.82 ml vs.742.85 ± 242.44 ml), the difference was statistically significant (all P <0.05); the hemoglobin decreased in the control group was higher than that in the observation group (2.14 ± 0.60 g / L vs 1.47 ± 0.42) g / L, the difference was statistically significant (P <0.05). Conclusion Prospective given to Xin Peipei can effectively reduce intraoperative and postoperative bleeding, reduce hemoglobin decline, it is worth promoting the use of the clinic.